Web Results

Seattle Genetics


Seattle Genetics is a biotechnology company focused on developing and commercializing ... Company LLC as well as ADC co-development agreements with Agensys, Inc., an affiliate of Astellas Pharma, In...

Seattle Genetics: Advancing Antibody-Drug Conjugates for Unmet ...


Advancing Antibody-Drug Conjugates for Cancer Seattle Genetics is a ... Seattle Genetics Initiates Phase 1 Trial of SGN-CD123A for Patients with Relapsed or .... Contact Us | Privacy Policy | Legal Notice ©2016 Seattle Genetics, Inc. You are ...

Seattle Genetics: Innovative Antibody-based Therapies for Cancer


Advancing Breakthrough Therapies for Cancer Seattle Genetics is a ...

Seattle Genetics: Contact Information


Contact information for and directions to Seattle Genetics, Inc., a biotechnology ...

Seattle Genetics: A Robust Pipeline


Our robust pipeline of empowered antibody-based therapies is designed to  ...

Seattle Genetics: Advancing Industry-Leading ADC Technology


Seattle Genetics' antibody-drug conjugate (ADC) technology empowers  ...

Seattle Genetics, Inc.: Job Opportunities


Put your passion to work at Seattle Genetics. The strength of the Seattle Genetics team resides in our collective commitment to patient care, individual excellence ...

SGEN : Summary for Seattle Genetics, Inc. - Yahoo Finance


View the basic SGEN stock chart on Yahoo Finance. Change the date range, chart type and compare Seattle Genetics, Inc. against other companies.

Seattle Genetics Reviews | Glassdoor


I have been working at Seattle Genetics full-time (More than 10 years). Pros. Focus on good science, ..... Seattle Genetics, Inc.: Investors & News : Press Release ...

Seattle Genetics, Inc.: NASDAQ:SGEN quotes & news - Google ...


Seattle Genetics, Inc. is a biotechnology company focused on the development and commercialization of therapies for the treatment of cancer. The Company's ...

More Info

Seattle Genetics: Career Opportunities


At Seattle Genetics, we are passionate about positively impacting the lives of ...

Seattle Genetics, Inc.: Investors & News : Stock Performance


SGEN (Common Stock). Exchange, NASDAQ (US Dollar). Price, $55.33.

Seattle Genetics, Inc.: Investors & News : Investors & News


Investors & News. Press Releases · Stock Performance · Webcasts.